Bisphosphonates and Jaw Osteonecrosis: Possible Serious Side Effect
Friday September 30, 2005
An article in the October issue of the Journal of Endodontics suggests that patients who take bisphosphonates (i.e., Fosamax (alendronate), Boniva (ibandronate), Actonel (risedronate), Aredia (pamidronate), and others) as part of treatment for conditions such as cancer, or bone conditions such as osteoporosis and Paget's disease of bone, may be at risk for developing a serious side effect - osteonecrosis of the jaw.
Related Resources:
- Osteoporosis Medications
- Guide to Osteonecrosis
- Osteoporosis Risk Factors
- Osteoporosis - What Arthritis Patients Should Know
- Jaw Osteonecrosis - Complication Tied to Bisphosphonates
- Pagets Disease of Bone and Osteoarthritis - Two Different Yet Related Conditions
Join the Discussion:
Photo by Amy Walters (iStockphoto)


Comments
No comments yet. Leave a Comment